Sponsor Pipeline

Institute of Hematology and Blood Transfusion, Czech Republic Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07532824 Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS Acute Myeloid Leukemia (AML) Recruiting
Phase 1
NCT05054257 CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia… Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Recruiting
Early Phase 1
NCT06765876 CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose… Leukemia, Myeloid, Acute(AML) Recruiting
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (2) Myelodysplastic Syndromes (MDS) (2) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Institute of Hematology and Blood Transfusion, Czech Republic's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free